Pathology as a discipline forms the foundation on which clinical treatment is initiated and the bedrock on which decisions regarding treatment modalities are chosen/taken or modified.

The Department of Histopathology – a subdivision of The Laboratory Services of Sri Ramakrishna Hospital, Coimbatore is strengthened by a team of experienced and skilled consultant Pathologists in Coimbatore who have sound expertise in Oncopathology, Uropathology, Gynecologic Pathology, Gastro-intestinal pathology, Pulmonary pathology, Hematopathology, Fetal autopsy etc..,

Our department is equipped with state-of-the-art facility in analyzing diverse biopsy specimen which includes of a gamut of diagnostic small biopsies to large surgical resection specimen, FNA/ Exfoliative / brush / serous cavity cytology samples, Frozen section (Intraoperative consultation), Immunohistochemistry,Dual in situ hybridization for HER2 gene, Bone marrow studies, Flowcytometry and Cytochemistry..

Our strengths

1. High quality tissue processing with automated tissue processor (LEICA)
2. A dedicated and trained team of support staff to maintain a well oiled smooth workflow system/ practice. Excellent section cutting and staining by our team of committed, experienced, talented and skilled histopathology technicians
3. A whole range of Histochemical special stains to confirm histopathology findings as part of evidence based medicine
4. Immunohistochemistry on Automated platform (VENTANA Benchmark GX[Roche] – 2 machines) with wide array of IHC (more than 100) markers
5. Automated Dual in situ hybridization for HER2 gene (D-DISH)
6. Frozen section reporting
7. Second opinion (Slide and block review) for patients evaluated initially at other centres

Accurate and timely diagnosis is a key link in patient treatment management and every effort is made in the functioning of our department to uphold this.The efficacy of every test or system of practice of Histopathology adopted in our Department is continually monitored by daily inhouse Quality Control protocols comparable with standards of QCI, participation in External Quality Assurance programs (NCG EQAS) and by adopting CAP protocol for reporting malignancy in surgical specimens